PB2143: PROGNOSTIC SIGNIFICANCE AND CLINICAL APPLICABILITY OF THE COMORBIDITY INDICES IN PATIENTS WITH MULTIPLE MYELOMA: IMWG AND SARC-F SCORE

• Nikola Vukosavljevic,
• Zoran Milojevic,
• Katarina Markovic,
• Aleksandra Sretenovic,
• Marko Mitrovic,
• Nevenka Markovic,
• Dusica Davidovic,
• Miroslav Pavlovic,
• Tijana Markovic-Dobrijevic,
• Marija Cakarevic,
• Jelena Bila

Affiliations

Nikola Vukosavljevic

1 University Medical Center Zvezdara, Department of Hematology, Belgrade, Serbia

Zoran Milojevic

1 University Medical Center Zvezdara, Department of Hematology, Belgrade, Serbia

Katarina Markovic

1 University Medical Center Zvezdara, Department of Hematology, Belgrade, Serbia

Aleksandra Sretenovic

2 University Clinical Center of Serbia, Clinic of Hematology, Belgrade, Serbia

Marko Mitrovic

2 University Clinical Center of Serbia, Clinic of Hematology, Belgrade, Serbia

Nevenka Markovic

1 University Medical Center Zvezdara, Department of Hematology, Belgrade, Serbia

Dusica Davidovic

1 University Medical Center Zvezdara, Department of Hematology, Belgrade, Serbia

Miroslav Pavlovic

1 University Medical Center Zvezdara, Department of Hematology, Belgrade, Serbia

Tijana Markovic-Dobrijevic

1 University Medical Center Zvezdara, Department of Hematology, Belgrade, Serbia

Marija Cakarevic

1 University Medical Center Zvezdara, Department of Hematology, Belgrade, Serbia

Jelena Bila

2 University Clinical Center of Serbia, Clinic of Hematology, Belgrade, Serbia